India: A recent study published in Diabetologia has shed light on a unique presentation of type 2 diabetes among young adults in Assam, India—one that defies the conventional link between…
UK: A subanalysis of the DAPA-MI trial, published in the Journal of the American Heart Association, reveals that dapagliflozin significantly reduces the risk of developing type 2 diabetes and heart…
New Delhi: The Delhi High Court has directed the Central Drugs Standard Control Organisation (CDSCO) not to enforce its order initiating criminal prosecution against IndiaMART Intermesh Limited over alleged listings…
New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has recommended approval of an updated package insert for Rybelsus tablets (3 mg, 7 mg,…
A new study published in the journal of Diabetes Research and Clinical Practice found that dapagliflozin and empagliflozin commonly used SGLT2 inhibitors for type 2 diabetes (T2D), deliver comparable real-world benefits…
A new study published in the journal of Cureus found a hidden cardiovascular risk in patients with type 2 diabetes mellitus (DM). This research have confirmed that coronary microvascular dysfunction…
New research indicates that many patients who undergo surgery with the intent to cure early-stage cancer continue or start opioid prescriptions in the year following surgery. The findings are published…
A new study published in the journal of Gastro Hep Advances found that long-term prednisone therapy in patients with autoimmune hepatitis cirrhosis (AIH) to increase the risk of developing hepatocellular carcinoma…
People with both type 2 diabetes (T2D) and obstructive sleep apnoea have a higher risk of death, but treatment with continuous positive airway pressure (CPAP) may reduce that risk by…
Netherlands: Researchers have found in a new study that fractional flow reserve–guided complete revascularization during the index procedure is effective for patients with non–ST-segment elevation myocardial infarction (NSTEMI) and multivessel…